TXG earnings
10x Genomics (TXG) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
TXG earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.14 | -0.24 | 42.41% | $151.04M |
| Q1 2026 | May 7, 2026 | -0.10 | -0.29 | 65.52% | $150.84M |
| Q4 2025 | Feb 12, 2026 | -0.13 | -0.19 | 31.58% | $166.03M |
| Q3 2025 | Nov 6, 2025 | -0.22 | -0.07 | -214.29% | $149.00M |
| Q2 2025 | Aug 7, 2025 | 0.28 | -0.35 | 180.00% | $172.91M |
| Q1 2025 | May 8, 2025 | -0.36 | -0.45 | 20.00% | $154.88M |
| Q4 2024 | Feb 12, 2025 | -0.40 | -0.29 | -37.93% | $165.02M |
| Q3 2024 | Oct 29, 2024 | -0.30 | -0.34 | 11.76% | $151.65M |
| Q2 2024 | Aug 8, 2024 | -0.32 | -0.47 | 31.91% | $153.10M |
| Q1 2024 | Apr 30, 2024 | -0.50 | -0.46 | -8.70% | $141.01M |
| Q4 2023 | Feb 15, 2024 | -0.41 | -0.36 | -13.89% | $183.98M |
| Q3 2023 | Nov 1, 2023 | -0.51 | -0.45 | -13.33% | $153.64M |
| Aug 3, 2023 | -0.53 | -0.39 | -35.90% | – | |
| May 3, 2023 | -0.44 | -0.38 | -15.79% | – | |
| Feb 15, 2023 | -0.15 | -0.29 | 48.28% | – | |
| Nov 2, 2022 | -0.37 | -0.45 | 17.78% | – | |
| Aug 8, 2022 | -0.57 | -0.40 | -42.50% | – | |
| May 4, 2022 | -0.38 | -0.37 | -2.70% | – | |
| Feb 16, 2022 | -0.16 | -0.06 | -166.67% | – | |
| Nov 3, 2021 | -0.15 | -0.18 | 16.67% | – |
- TXG reports next on Nov 5, 2026, with EPS of -0.26 expected.
- TXG beat EPS estimates in 16 of its last 28 reports.
Updated 2026-11-02 19:12 UTC